HONORING STEVEN M. DUBINETT, M.D. 2019 WILLIAM S. MIDDLETON AWARD WINNER; Congressional Record Vol. 166, No. 80
(Extensions of Remarks - April 28, 2020)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.


[Extensions of Remarks]
[Page E404]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




   HONORING STEVEN M. DUBINETT, M.D. 2019 WILLIAM S. MIDDLETON AWARD 
                                 WINNER

                                 ______
                                 

                             HON. TED LIEU

                             of california

                    in the house of representatives

                        Tuesday, April 28, 2020

  Mr. LIEU of California. Madam Speaker, on behalf of the United States 
House of Representatives, I would like to extend my heartfelt 
congratulations to Dr. Steven M. Dubinett--a pulmonologist, professor, 
and researcher at the VA Greater Los Angeles Healthcare System--in 
recognition of his lifesaving contributions to the field of oncology 
and lung cancer research.
  The William S. Middleton award is the VA Biomedical Laboratory 
Research and Development Service's (BLR&D) highest honor. Named for the 
VA's chief medical director between 1955 and 1963, it is reserved for 
individuals who have made exceptional contributions to biomedical and 
bio-behavioral research that is relevant to the lives of veterans.
  As many people know, the VA Greater Los Angeles Healthcare System 
(VAGLAHS) is a beacon in the community and indeed the country for high 
caliber researchers who dedicate their careers to improving the quality 
of life of those who have served. Dr. Dubinett is an exemplary 
representative for both VAGLAHS and his profession.
  In addition to his admirable dedication to service, his work proves 
the valuable connection between basic research and real-world treatment 
applications. His research has directly led to a new treatment regimen 
and immunotherapy trials for lung cancer patients.
  As a veteran, I have worked hard to ensure that our nation's service 
members are given the chance they deserve to succeed. I am always 
deeply moved by the work our partners do at the VA, in the non-profit 
sector, and at the state and local level to improve outcomes for our 
nation's veterans. That work--and all the headway we have made--is 
threatened by every new case of cancer, our progress undermined each 
time we fail to beat what has claimed the lives of too many veterans at 
home. Simply put, Dr. Dubinett is one of our most valuable allies in 
that fight.
  From his work on in situ vaccination strategies and his research for 
the National Lung Screening Trial, to his membership on philanthropic 
boards and his mentorship of the next generation of scientists, the 
American people owe Dr. Dubinett a debt of gratitude. I am honored to 
count him among my constituents.

                          ____________________